Oral administration of insulin as poly(vinyl alcohol)-gel spheres in diabetic rats

Toshikiro Kimura, Kazunari Sato, Katsuyoshi Sugimoto, Ritsuko Tao, Tsuyoshi Murakami, Yuji Kurosaki, Taiji Nakayama

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

The oral administration of insulin in poly(vinyl alcohol)-gel spheres (PVA-GS), an oral dosage form with prolonged residence time in the ileum, was examined in streptozotocin-induced diabetic rats. Intragastric administration of PVA-GS containing insulin and a protease inhibitor, aprotinin or bacitracin, caused a significant and prolonged reduction of blood glucose levels. suggesting insulin absorption. The bioavailability of insulin estimated from the hypoglycemic effect was about 2% in the presence of either protease inhibitor. The release profiles of insulin and the protease inhibitors from the PVA-GS could be explained by Higuchi's plot, and the rates were similar to each other. The site dependency of insulin absorption in the intestinal tract was examined by an in situ loop method. Insulin absorption estimated by plasma insulin levels was larger in the ileum and the large intestine than in the jejunum. The prolonged residence time of PVA-GS in the absorption site, the lower intestine, and the synchronous release of insulin and the protease inhibitors from the PVA-GS are the two major explanations for the improved bioavailability of insulin administered as PVA- GS containing a protease inhibitor.

Original languageEnglish
Pages (from-to)897-900
Number of pages4
JournalBiological and Pharmaceutical Bulletin
Volume19
Issue number6
Publication statusPublished - Jun 1996

Fingerprint

Oral Administration
Gels
Alcohols
Protease Inhibitors
Insulin
Insulysin
Ileum
Biological Availability
Bacitracin
Aprotinin
Large Intestine
Intestinal Absorption
Dosage Forms
Jejunum
Streptozocin
Hypoglycemic Agents
Intestines
Blood Glucose

Keywords

  • diabetic rat
  • insulin
  • oral administration
  • poly(vinyl alcohol)-gel sphere
  • prolonged gastrointestinal residence time
  • protease inhibitor

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Kimura, T., Sato, K., Sugimoto, K., Tao, R., Murakami, T., Kurosaki, Y., & Nakayama, T. (1996). Oral administration of insulin as poly(vinyl alcohol)-gel spheres in diabetic rats. Biological and Pharmaceutical Bulletin, 19(6), 897-900.

Oral administration of insulin as poly(vinyl alcohol)-gel spheres in diabetic rats. / Kimura, Toshikiro; Sato, Kazunari; Sugimoto, Katsuyoshi; Tao, Ritsuko; Murakami, Tsuyoshi; Kurosaki, Yuji; Nakayama, Taiji.

In: Biological and Pharmaceutical Bulletin, Vol. 19, No. 6, 06.1996, p. 897-900.

Research output: Contribution to journalArticle

Kimura, T, Sato, K, Sugimoto, K, Tao, R, Murakami, T, Kurosaki, Y & Nakayama, T 1996, 'Oral administration of insulin as poly(vinyl alcohol)-gel spheres in diabetic rats', Biological and Pharmaceutical Bulletin, vol. 19, no. 6, pp. 897-900.
Kimura, Toshikiro ; Sato, Kazunari ; Sugimoto, Katsuyoshi ; Tao, Ritsuko ; Murakami, Tsuyoshi ; Kurosaki, Yuji ; Nakayama, Taiji. / Oral administration of insulin as poly(vinyl alcohol)-gel spheres in diabetic rats. In: Biological and Pharmaceutical Bulletin. 1996 ; Vol. 19, No. 6. pp. 897-900.
@article{651694197c9944efae9ae04d577a64d2,
title = "Oral administration of insulin as poly(vinyl alcohol)-gel spheres in diabetic rats",
abstract = "The oral administration of insulin in poly(vinyl alcohol)-gel spheres (PVA-GS), an oral dosage form with prolonged residence time in the ileum, was examined in streptozotocin-induced diabetic rats. Intragastric administration of PVA-GS containing insulin and a protease inhibitor, aprotinin or bacitracin, caused a significant and prolonged reduction of blood glucose levels. suggesting insulin absorption. The bioavailability of insulin estimated from the hypoglycemic effect was about 2{\%} in the presence of either protease inhibitor. The release profiles of insulin and the protease inhibitors from the PVA-GS could be explained by Higuchi's plot, and the rates were similar to each other. The site dependency of insulin absorption in the intestinal tract was examined by an in situ loop method. Insulin absorption estimated by plasma insulin levels was larger in the ileum and the large intestine than in the jejunum. The prolonged residence time of PVA-GS in the absorption site, the lower intestine, and the synchronous release of insulin and the protease inhibitors from the PVA-GS are the two major explanations for the improved bioavailability of insulin administered as PVA- GS containing a protease inhibitor.",
keywords = "diabetic rat, insulin, oral administration, poly(vinyl alcohol)-gel sphere, prolonged gastrointestinal residence time, protease inhibitor",
author = "Toshikiro Kimura and Kazunari Sato and Katsuyoshi Sugimoto and Ritsuko Tao and Tsuyoshi Murakami and Yuji Kurosaki and Taiji Nakayama",
year = "1996",
month = "6",
language = "English",
volume = "19",
pages = "897--900",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "6",

}

TY - JOUR

T1 - Oral administration of insulin as poly(vinyl alcohol)-gel spheres in diabetic rats

AU - Kimura, Toshikiro

AU - Sato, Kazunari

AU - Sugimoto, Katsuyoshi

AU - Tao, Ritsuko

AU - Murakami, Tsuyoshi

AU - Kurosaki, Yuji

AU - Nakayama, Taiji

PY - 1996/6

Y1 - 1996/6

N2 - The oral administration of insulin in poly(vinyl alcohol)-gel spheres (PVA-GS), an oral dosage form with prolonged residence time in the ileum, was examined in streptozotocin-induced diabetic rats. Intragastric administration of PVA-GS containing insulin and a protease inhibitor, aprotinin or bacitracin, caused a significant and prolonged reduction of blood glucose levels. suggesting insulin absorption. The bioavailability of insulin estimated from the hypoglycemic effect was about 2% in the presence of either protease inhibitor. The release profiles of insulin and the protease inhibitors from the PVA-GS could be explained by Higuchi's plot, and the rates were similar to each other. The site dependency of insulin absorption in the intestinal tract was examined by an in situ loop method. Insulin absorption estimated by plasma insulin levels was larger in the ileum and the large intestine than in the jejunum. The prolonged residence time of PVA-GS in the absorption site, the lower intestine, and the synchronous release of insulin and the protease inhibitors from the PVA-GS are the two major explanations for the improved bioavailability of insulin administered as PVA- GS containing a protease inhibitor.

AB - The oral administration of insulin in poly(vinyl alcohol)-gel spheres (PVA-GS), an oral dosage form with prolonged residence time in the ileum, was examined in streptozotocin-induced diabetic rats. Intragastric administration of PVA-GS containing insulin and a protease inhibitor, aprotinin or bacitracin, caused a significant and prolonged reduction of blood glucose levels. suggesting insulin absorption. The bioavailability of insulin estimated from the hypoglycemic effect was about 2% in the presence of either protease inhibitor. The release profiles of insulin and the protease inhibitors from the PVA-GS could be explained by Higuchi's plot, and the rates were similar to each other. The site dependency of insulin absorption in the intestinal tract was examined by an in situ loop method. Insulin absorption estimated by plasma insulin levels was larger in the ileum and the large intestine than in the jejunum. The prolonged residence time of PVA-GS in the absorption site, the lower intestine, and the synchronous release of insulin and the protease inhibitors from the PVA-GS are the two major explanations for the improved bioavailability of insulin administered as PVA- GS containing a protease inhibitor.

KW - diabetic rat

KW - insulin

KW - oral administration

KW - poly(vinyl alcohol)-gel sphere

KW - prolonged gastrointestinal residence time

KW - protease inhibitor

UR - http://www.scopus.com/inward/record.url?scp=0030006079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030006079&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 897

EP - 900

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 6

ER -